Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
PHASE2
Obesity is a medical condition which increases the risk of other diseases, ...
Status
Completed
Location
Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University and Section for Diabetes and Endocrinology at the Uppsala University Hospital
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
PHASE4
Global Burden of Diseases ranks chronic kidney disease (CKD) as the 12th le...